JUCTCi010-A

Registration Summary:

A P E C

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	JUCTCi010-A
Cite as:	JUCTCi010-A (RRID:CVCL_ZV36)
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	22nd December 2019
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	the University of Jordan / Cell Therapy center (JUCTC)
External Databases
Cellosaurus	CVCL_ZV36
Wikidata	Q98126807
General Information
Publications	Ababneh NA et al. Establishment of a human induced pluripotent stem cell (iPSC) line (JUCTCi010-A) from a healthy Jordanian female skin dermal fibroblasts. Stem cell research. 2020 Jun 24;47:101891. Tang Yuanzhang et al. Enhanced Cell Penetration and Pluripotency Maintenance of hiPSCs in 3D Natural Chitosan Scaffolds. Macromolecular Bioscience. 2023-06-00. Alwohoush Enas et al. Effect of hypoxia on proliferation and differentiation of induced pluripotent stem cell-derived mesenchymal stem cells. Heliyon. 2024-10-00. A Ababneh N et al. Establishment of a human induced pluripotent stem cell (iPSC) line (JUCTCi018-A) from a patient with Charcot-Marie-Tooth disease type 2EE (CMT2EE) due to a homozygous c.122G > A p.(Arg41Gln) mutation in the MPV17 gene. Stem cell research. 2024 Dec;81:103602. Vitillo L et al. Gain of 20q11.21 in human pluripotent stem cells enhances differentiation to retinal pigment epithelium. Stem cell research & therapy. 2025 Feb 21;16(1):82. Gharandouq Mohammad H. et al. Metformin Protects Human Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons from Oxidative Damage Through Antioxidant Mechanisms. Neurotoxicity Research. 2025-04-00.

hIPSC Derivation

General